Isoflurane - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for isoflurane and what is the scope of freedom to operate?
Isoflurane
is the generic ingredient in two branded drugs marketed by Baxter Hlthcare, Halocarbon Prods, Hospira, Piramal Critical, Piramal Pharma, Shandong, and Watson Labs Inc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for isoflurane. Six suppliers are listed for this compound.
Summary for isoflurane
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 7 |
| NDAs: | 7 |
| Drug Master File Entries: | 8 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 295 |
| Patent Applications: | 5,836 |
| What excipients (inactive ingredients) are in isoflurane? | isoflurane excipients list |
| DailyMed Link: | isoflurane at DailyMed |
Recent Clinical Trials for isoflurane
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Liaquat National Hospital & Medical College | PHASE1 |
| Xijing Hospital | PHASE3 |
| Jinnah Postgraduate Medical Centre | PHASE1 |
Pharmacology for isoflurane
| Drug Class | General Anesthetic |
| Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for isoflurane
Anatomical Therapeutic Chemical (ATC) Classes for isoflurane
US Patents and Regulatory Information for isoflurane
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shandong | ISOFLURANE | isoflurane | LIQUID;INHALATION | 216527-001 | Nov 4, 2025 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Baxter Hlthcare | FORANE | isoflurane | LIQUID;INHALATION | 017624-001 | Approved Prior to Jan 1, 1982 | AN | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Piramal Critical | ISOFLURANE | isoflurane | LIQUID;INHALATION | 074416-001 | Sep 30, 1994 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hospira | ISOFLURANE | isoflurane | LIQUID;INHALATION | 074097-001 | Jan 25, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for isoflurane
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | FORANE | isoflurane | LIQUID;INHALATION | 017624-001 | Approved Prior to Jan 1, 1982 | ⤷ Start Trial | ⤷ Start Trial |
| Baxter Hlthcare | FORANE | isoflurane | LIQUID;INHALATION | 017624-001 | Approved Prior to Jan 1, 1982 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch